According to the prognosis data from TCGA Program, HCC patients with high LINC01004 expression had significantly poorer disease-free survival (DFS) than patients with low LINC01004 expression (Fig. 2B). The gene discussed is KMT2E-AS1; the disease is hepatocellular carcinoma.